ABERNETHY MATT
SEC insider (Form 3/4/5 filer). CIK 0001724097. Chief Financial Officer at NEUROCRINE BIOSCIENCES INC (NBIX) and 1 other issuer. 26 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in SAN DIEGO, CA.
Companies ABERNETHY MATT has filed insider reports for
- NEUROCRINE BIOSCIENCES INC (NBIX): Officer, Chief Financial Officer
- FATE THERAPEUTICS INC (FATE): Director
ABERNETHY MATT
CIK: 0001724097
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Sep 14, 2026NBIX
NEUROCRINE BIOSCIENCES INC
SaleDirect2.3K shares at avg. $157.20$363K - Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax PaymentDirect2.7K shares at avg. $156.22$423K - Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirect5K shares- - Jun 12, 2026FATE
FATE THERAPEUTICS INC
AwardDirectStock Option (Right to Buy)
87.9K shares- - Mar 4, 2026NBIX
NEUROCRINE BIOSCIENCES INC
GiftDirect2.2K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect2.2K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax PaymentDirect5.4K shares at avg. $124.12$668K - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect2.6K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax PaymentDirect1.4K shares at avg. $124.12$172K - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax PaymentDirect1.2K shares at avg. $124.12$150K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 |  NBIX NEUROCRINE BIOSCIENCES INC | Sale | 2,311 | $157.20 | $363,285 | Direct |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment | 2,709 | $156.22 | $423,200 | Direct |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award | 5,020 | - | $0 | Direct |
| Jun 12, 2026 |  FATE FATE THERAPEUTICS INC | Award Stock Option (Right to Buy) | 87,900 | - | - | Direct |
| Mar 4, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Gift | 2,249 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 2,241 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment | 5,378 | $124.12 | $667,517 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 2,566 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment | 1,385 | $124.12 | $171,906 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment | 1,210 | $124.12 | $150,185 | Direct |
1-10 of 26 transactions